<p>Ampliphi Biosciences Corp（NYSEAMERICAN:APHB - 获取免费报告）周三上涨了 9.3%。该股票最高交易价为$9.59，最后交易价为$9.54。在午盘交易中，约有 133,273 股成交，较平均每日成交量 842,200 股下降了 84%。该股票此前收盘价为$8.73。</p>
<p>获取 <strong>Ampliphi Biosciences</strong> 的提醒：</p>
<h2>Ampliphi Biosciences 股票表现</h2>
<p>该公司的 50 日移动平均线为$6.96，200 日移动平均线为$5.17。</p>
<h2>Ampliphi Biosciences 公司简介</h2>
<p>（获取免费报告）</p>
<p>Ampliphi Biosciences, Inc 是一家总部位于马萨诸塞州剑桥的临床阶段生物制药公司，专注于发现和开发新型疗法，以预防和治疗危及生命的耐药性感染。公司的核心使命是通过推进首创和最佳抗菌药物的晚期临床试验，解决日益严重的抗生素耐药性全球威胁。</p>
<p>该公司的主要产品候选药物 exeporfinium chloride（XF-73）是一种开创性的局部抗菌药物，旨在为接受高风险手术的患者进行术前鼻腔去殖民化，以去除金黄色葡萄球菌。</p>
<h2>了解更多</h2>
<ul>
<li>我们更看好的五只股票比 Ampliphi Biosciences 更好</li>
<li>华尔街害怕的黄金图表……</li>
<li>美国的 1776 再次发生</li>
<li>这让我感到愤怒</li>
<li>在 2026 年 5 月之前购买这只黄金股票</li>
<li>一位前 CIA 特工对即将到来的崩溃的看法</li>
</ul>
<p><em>此即时新闻提醒由叙述科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快的报道和公正的覆盖。请将任何问题或意见发送至 contact@marketbeat.com。</em></p>
<h2>你现在应该投资$1,000 在 Ampliphi Biosciences 吗？</h2>
<p>在考虑 Ampliphi Biosciences 之前，你需要听听这个。</p>
<p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只股票，顶级分析师正在悄悄地向客户推荐在更广泛的市场注意到之前购买……而 Ampliphi Biosciences 并不在名单上。</p>
<p>虽然 Ampliphi Biosciences 目前在分析师中被评为持有评级，但顶级分析师认为这五只股票更值得购买。</p>
<p>在这里查看这五只股票</p>

2 倍做多纳斯达克生物技术 ETF - ProShares

生物科技 ETF - VanEck Vectors

医疗业 ETF - SPDR

<p>Ampliphi Biosciences（纽约证券交易所代码：APHB）的股价上涨了 9.3%，交易价格为 9.54 美元，最高达到 9.59 美元。尽管股价上涨，交易量却比平均水平下降了 84%，共交易了 133,273 股。该公司专注于开发针对耐药性感染的治疗方案，其主要产品是用于术前鼻腔去殖的 exeporfinium chloride。分析师目前对该股票的评级为持有，暗示可能有更好的投资选择</p>

<p>Ampliphi Biosciences Corp (NYSEAMERICAN:APHB - Get Free Report) was up 9.3% on Wednesday . The stock traded as high as $9.59 and last traded at $9.54. Approximately 133,273 shares traded hands during mid-day trading, a decline of 84% from the average daily volume of 842,200 shares. The stock had previously closed at $8.73.</p>
<div class="lb-trans"><p>Ampliphi Biosciences Corp（NYSEAMERICAN:APHB - 获取免费报告）周三上涨了 9.3%。该股票最高交易价为$9.59，最后交易价为$9.54。在午盘交易中，约有 133,273 股成交，较平均每日成交量 842,200 股下降了 84%。该股票此前收盘价为$8.73。</p>
</div><p>Get <strong>Ampliphi Biosciences</strong> alerts:</p>
<div class="lb-trans"><p>获取 <strong>Ampliphi Biosciences</strong> 的提醒：</p>
</div><h2>Ampliphi Biosciences Stock Performance</h2>
<div class="lb-trans"><h2>Ampliphi Biosciences 股票表现</h2>
</div><p>The business has a 50 day moving average of $6.96 and a 200-day moving average of $5.17.</p>
<div class="lb-trans"><p>该公司的 50 日移动平均线为$6.96，200 日移动平均线为$5.17。</p>
</div><h2>Ampliphi Biosciences Company Profile</h2>
<div class="lb-trans"><h2>Ampliphi Biosciences 公司简介</h2>
</div><p>(Get Free Report)</p>
<div class="lb-trans"><p>（获取免费报告）</p>
</div><p>Ampliphi Biosciences, Inc is a clinical‐stage biopharmaceutical company headquartered in Cambridge, Massachusetts, focused on the discovery and development of novel therapies to prevent and treat life‐threatening drug‐resistant infections. The company's core mission is to address the growing global threat of antibiotic resistance by advancing first‐in‐class and best‐in‐class antibacterial agents through late‐stage clinical trials.</p>
<div class="lb-trans"><p>Ampliphi Biosciences, Inc 是一家总部位于马萨诸塞州剑桥的临床阶段生物制药公司，专注于发现和开发新型疗法，以预防和治疗危及生命的耐药性感染。公司的核心使命是通过推进首创和最佳抗菌药物的晚期临床试验，解决日益严重的抗生素耐药性全球威胁。</p>
</div><p>The company's lead product candidate, exeporfinium chloride (XF-73), is a pioneering topical antibacterial designed for pre‐operative nasal decolonization of Staphylococcus aureus in patients undergoing high‐risk surgical procedures.</p>
<div class="lb-trans"><p>该公司的主要产品候选药物 exeporfinium chloride（XF-73）是一种开创性的局部抗菌药物，旨在为接受高风险手术的患者进行术前鼻腔去殖民化，以去除金黄色葡萄球菌。</p>
</div><h2>Read More</h2>
<div class="lb-trans"><h2>了解更多</h2>
</div><ul>
<li>Five stocks we like better than Ampliphi Biosciences</li>
<li>The gold chart Wall Street is terrified of…</li>
<li>America’s 1776 happening again</li>
<li>This makes me furious</li>
<li>Buy this Gold Stock Before May 2026</li>
<li>What a Former CIA Agent Knows About the Coming Collapse</li>
</ul>
<div class="lb-trans"><ul>
<li>我们更看好的五只股票比 Ampliphi Biosciences 更好</li>
<li>华尔街害怕的黄金图表……</li>
<li>美国的 1776 再次发生</li>
<li>这让我感到愤怒</li>
<li>在 2026 年 5 月之前购买这只黄金股票</li>
<li>一位前 CIA 特工对即将到来的崩溃的看法</li>
</ul>
</div><p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即时新闻提醒由叙述科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快的报道和公正的覆盖。请将任何问题或意见发送至 contact@marketbeat.com。</em></p>
</div><h2>Should You Invest $1,000 in Ampliphi Biosciences Right Now?</h2>
<div class="lb-trans"><h2>你现在应该投资$1,000 在 Ampliphi Biosciences 吗？</h2>
</div><p>Before you consider Ampliphi Biosciences, you'll want to hear this.</p>
<div class="lb-trans"><p>在考虑 Ampliphi Biosciences 之前，你需要听听这个。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Ampliphi Biosciences wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只股票，顶级分析师正在悄悄地向客户推荐在更广泛的市场注意到之前购买……而 Ampliphi Biosciences 并不在名单上。</p>
</div><p>While Ampliphi Biosciences currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>虽然 Ampliphi Biosciences 目前在分析师中被评为持有评级，但顶级分析师认为这五只股票更值得购买。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在这里查看这五只股票</p>
</div>

Ampliphi Biosciences (NYSEAMERICAN:APHB) Trading Up 9.3%  - What's Next?

Market Beat

医药突破 ETF - ALPS

医疗业 ETF - Vanguard

标普生物技术 ETF - SPDR

APTOSE BIOSCIENCES INC

纽交所高增长板生物技术指数 ETF - First Trust

动态生物技术与基因组 ETF - Invesco

MBX Biosciences

纳斯达克生物科技指数 ETF - iShares Nasdaq

美国制药 ETF - iShares

Invesco Nasdaq Biotechnology ETF

Ampliphi Biosciences (NYSEAMERICAN:APHB) 股价上涨了 9.3% - 接下来会发生什么？